For following the competition: what moved in each program, several studies read as one move.
- efserakefusp alfa
- Erdafitinib-releasing Intravesical System TAR-210
- nogapendekin alfa inbakicept
- + 18 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Non-Muscle Invasive Bladder Neoplasms to watchlistEvery Monday by email · turn it off any timePro · free during the beta